IDO1 and endometrial cancer: It should be noted that baseline Kyn levels in our patient cohort were higher than those measured in healthy controls (median Kyn concentration = 1.86 μM; number of samples = 20), probably reflecting the expression of functional IDO1 by the ovarian and endometrial cancer cells [39].